Literature DB >> 20688965

The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD).

Peter Valent, Michel Arock, Cem Akin, Wolfgang R Sperr, Andreas Reiter, Karl Sotlar, Karin Hartmann, Tracy I George, Knut Brockow, Hanneke C Kluin-Nelemans, Jason Gotlib, Dean D Metcalfe, Hans-Peter Horny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20688965      PMCID： PMC2918335          DOI： 10.1182/blood-2010-05-285270

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Proposal for a revised classification of systemic mastocytosis.

Authors:  Animesh Pardanani; Ayalew Tefferi
Journal:  Blood       Date:  2010-04-01       Impact factor: 22.113

Review 2.  Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.

Authors:  H-P Horny; K Sotlar; P Valent
Journal:  Pathobiology       Date:  2010-07-07       Impact factor: 4.342

3.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

4.  Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Authors:  Iván Alvarez-Twose; David González de Olano; Laura Sánchez-Muñoz; Almudena Matito; Maria I Esteban-López; Arantza Vega; Maria Belén Mateo; Maria D Alonso Díaz de Durana; Belén de la Hoz; Maria D Del Pozo Gil; Teresa Caballero; Ana Rosado; Isabel Sánchez Matas; Cristina Teodósio; María Jara-Acevedo; Manuela Mollejo; Andrés García-Montero; Alberto Orfao; Luis Escribano
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

Review 5.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

6.  Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).

Authors:  Karl Sotlar; Sema Colak; Anja Bache; Sabina Berezowska; Manuela Krokowski; Burkhard Bültmann; Peter Valent; Hans-Peter Horny
Journal:  J Pathol       Date:  2010-04       Impact factor: 7.996

Review 7.  Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

Authors:  P Valent; C Akin; L Escribano; M Födinger; K Hartmann; K Brockow; M Castells; W R Sperr; H C Kluin-Nelemans; N A T Hamdy; O Lortholary; J Robyn; J van Doormaal; K Sotlar; A W Hauswirth; M Arock; O Hermine; A Hellmann; M Triggiani; M Niedoszytko; L B Schwartz; A Orfao; H-P Horny; D D Metcalfe
Journal:  Eur J Clin Invest       Date:  2007-06       Impact factor: 4.686

Review 8.  Mastocytosis: state of the art.

Authors:  Hans-Peter Horny; Karl Sotlar; Peter Valent
Journal:  Pathobiology       Date:  2007       Impact factor: 4.342
  8 in total
  6 in total

1.  Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.

Authors:  Hanneke C Kluin-Nelemans; Andreas Reiter; Anja Illerhaus; Bjorn van Anrooij; Karin Hartmann; Lambertus F R Span; Aleksandra Gorska; Marek Niedoszytko; Magdalena Lange; Luigi Scaffidi; Roberta Zanotti; Patrizia Bonadonna; Cecelia Perkins; Chiara Elena; Luca Malcovati; Khalid Shoumariyeh; Nikolas von Bubnoff; Roberta Parente; Massimo Triggiani; Juliana Schwaab; Mohamad Jawhar; Francesca Caroppo; Anna Belloni Fortina; Knut Brockow; Alexander Zink; David Fuchs; Alex Kilbertus; Akif Selim Yavuz; Michael Doubek; Mattias Mattsson; Hans Hagglund; Jens Panse; Vito Sabato; Elisabeth Aberer; Dietger Niederwieser; Christine Breynaert; Judit Várkonyi; Vanessa Kennedy; Olivier Lortholary; Thilo Jakob; Olivier Hermine; Julien Rossignol; Michel Arock; Jason Gotlib; Peter Valent; Wolfgang R Sperr
Journal:  Leukemia       Date:  2019-11-18       Impact factor: 11.528

Review 2.  Systemic mastocytosis: a gastroenterological perspective.

Authors:  Hamish Philpott; Paul Gow; Peter Crowley; Sanjay Nandurkar; Jo Douglass; Peter R Gibson
Journal:  Frontline Gastroenterol       Date:  2011-09-10

Review 3.  Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.

Authors:  Katerina Zoi; Nicholas C P Cross
Journal:  Int J Hematol       Date:  2014-09-12       Impact factor: 2.490

4.  Serum total tryptase level confirms itself as a more reliable marker of mast cells burden in mast cell leukaemia (aleukaemic variant).

Authors:  P Savini; M Rondoni; G Poletti; A Lanzi; O Quercia; S Soverini; C De Benedittis; G Musardo; G Martinelli; G F Stefanini
Journal:  Case Rep Hematol       Date:  2015-02-10

5.  A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.

Authors:  Siham Bibi; Yanyan Zhang; Caroline Hugonin; Mallorie Depond Mangean; Liang He; Ghaith Wedeh; Jean-Marie Launay; Sjoerd Van Rijn; Thomas Würdinger; Fawzia Louache; Michel Arock
Journal:  Oncotarget       Date:  2016-12-13

Review 6.  Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.

Authors:  Srdan Verstovsek
Journal:  Eur J Haematol       Date:  2013-02       Impact factor: 2.997
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.